Antithrombin inhibition using nanobodies to correct bleeding in hemophilia

In this issue of EMBO Molecular Medicine, Barbon et al describe a new approach to rebalancing coagulation in patients with hemophilia (PWH) through targeted inhibition of anticoagulant antithrombin (AT) (Barbon et al, 2020). In contrast to previous studies that used RNA interference (RNAi) therapy t...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Sullivan, Jamie M, O'Donnell, James S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136951/
https://www.ncbi.nlm.nih.gov/pubmed/32212299
http://dx.doi.org/10.15252/emmm.202012143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136951/
https://www.ncbi.nlm.nih.gov/pubmed/32212299
http://dx.doi.org/10.15252/emmm.202012143

Ejemplares similares